Trial Profile
ZEST
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 15 Jun 2009
Price :
$35
*
At a glance
- Drugs Naproxcinod (Primary) ; Rofecoxib (Primary)
- Indications Musculoskeletal pain; Osteoarthritis
- Focus Therapeutic Use
- Acronyms ZEST
- Sponsors NicOx
- 15 Jun 2009 New trial record.